We are a leading and innovative pharmaceutical R&D company focused on inhaled product development for local and systemic delivery. We provide comprehensive solutions to the development processes and propose our technical platform. We had led successful projects in the EU, US and international markets. Through a deep expertise & knowledge around inhaled drug development & medical device engineering, Inhaled Therapeutics aims to become a leading company in the inhalation drug development. Its mission is to make inhaled drug technically & economically affordable through its multiple drug delivery platforms. The company's development program includes its Reservoir Dry Powder Inhaler (RDPI), a novel device technology plateform designed to deliver a large range of formulations including both small & large molecules. In all we do, we are driven by technology & innovation to provide better medicine at lower costs to address a large number of unmet needs